OQROGet OQRO Pro
Insider trade

Vir Biotechnology, Inc. (VIR)Officer sold ~$37K

Mark Eisner, Officer at Vir Biotechnology, Inc., sold ~$37K of Vir Biotechnology, Inc. shares.

~$37K
Approx. value · 6,796 sh @ $5.47
108K
Holds after · shares reported
Traded
Jul 15, 2025
Filed
Jul 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 2, 2025InsiderDirector sold ~$16K of VIR shares in the open market
  2. Jul 1, 2025InsiderDirector sold ~$112K of VIR shares in the open market
  3. Jul 15, 2025 · this disclosureInsiderOfficer sold ~$37K of VIR shares in the open market

What came next

  1. Jul 17, 2025InsiderOfficer sold ~$20K of VIR shares in the open market
  2. Aug 1, 2025InsiderDirector sold ~$110K of VIR shares in the open market
  3. Sep 2, 2025InsiderDirector sold ~$110K of VIR shares in the open market
  4. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Vir Biotechnology, Inc.

OQRO holds no insider, Congress, fund or contract record for Vir Biotechnology, Inc. dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VIR page.

Other recent filings by Mark Eisner, EVP and Chief Medical Officer

The full history of Mark Eisner, EVP and Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Vir Biotechnology, Inc.

Everything OQRO holds on this company is on its VIR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data